MicroRNA与胶质瘤关系的研究进展
作者: |
1,2张明,
2,3张金岭,
2,4车峰远
1 山东医学高等专科学校附属医院神经内科,山东 临沂 276004 2 临沂市脑肿瘤功能影像工程技术研究中心,山东 临沂 276004 3 临沂市人民医院肿瘤科,山东 临沂 276004 4 临沂市人民医院神经内科,山东 临沂 276004 |
通讯: |
车峰远
Email: Che1971@126.com |
DOI: | 10.3978/j.issn.2095-6959.2017.06.037 |
基金: | 临沂市级重点项目, 2016ZK001 山东省医药卫生科技发展项目, 2015WSA13031 |
摘要
胶质瘤是一种最常见的颅内肿瘤,约占所有颅内肿瘤的50%。MicroRNA是一种长为18~25 nt,进化上高度保守的内源性非编码小分子RNA。实验证据表明microRNA可通过调控其靶标基因参与的信号通路,影响肿瘤的发生和发展,发挥类似于癌基因或抑癌基因的功能。与正常脑组织相比,多种microRNA在许多胶质瘤组织中异常表达,为胶质瘤的诊断和治疗提供了新的策略。
关键词:
微小RNA
胶质瘤
分子标志物
Research progress of microRNA and glioma
CorrespondingAuthor: CHE Fengyuan Email: Che1971@126.com
DOI: 10.3978/j.issn.2095-6959.2017.06.037
Abstract
Glioma is the most common intracranial tumor, accounting for about 50% of all intracranial tumors. MicroRNA is a 18~25 nt, highly evolutionarily conserved endogenous non-coding small RNA. Experimental evidence indicates that microRNAs can play a role in tumorigenesis or tumor suppressor by regulating the signal pathways involved in their target genes, which may influence the genesis and development of tumors. There is growing evidence that a variety of microRNAs are expressed abnormally in many gliomas compared with normal brain tissue, providing a new strategy for the diagnosis and treatment of gliomas.